Carlos Alban
2018
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $821,930 |
|---|---|
| Non-Equity Incentive Plan | $1,836,219 |
| Option Awards | $961,216 |
| Salary | $1,016,526 |
| Stock Awards | $4,005,388 |
| Other | $341,800 |
| Total | $8,983,079 |
Alban received $4M in stock awards, accounting for 45% of the total pay in 2018.
Alban also received $821.9K of change in pension value and nonqualified deferred compensation earnings, $1.8M in non-equity incentive plan, $961.2K in option awards, $1M in salary and $341.8K in other compensation.
Rankings
In 2018, Carlos Alban's compensation ranked 837th out of 14,244 executives tracked by ExecPay. In other words, Alban earned more than 94.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 837 out of 14,244 | 94th |
Division Manufacturing | 281 out of 5,762 | 95th |
Major group Chemicals And Allied Products | 84 out of 2,125 | 96th |
Industry group Drugs | 66 out of 1,814 | 96th |
Industry Pharmaceutical Preparations | 45 out of 1,388 | 97th |
Pay ratio
| Carlos Alban's Pay | $8,983,079 |
|---|---|
| Median Employee's Pay | $148,823 |
| Pay Ratio | 60to 1 |
In 2018, the annual total compensation of Carlos Alban was $8,983,079.
The annual total compensation of the median employee at AbbVie was $148,823.
The ratio of Carlos Alban's pay to the pay of median employee was therefore 60 to one.
Alban's colleagues
We found five more compensation records of executives who worked with Carlos Alban at AbbVie in 2018.